[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-364952-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-364952-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","induction-of-necroptosis-in-lung-adenocarcinoma-by-mir10b5p-through-modulation-of-the-pkp3ripk3mlkl-cascade","Induction of necroptosis in lung adenocarcinoma by miR‑10b‑5p through modulation of the PKP3/RIPK3/MLKL cascade","","Lung adenocarcinoma remains a leading cause of cancer mortality, driving the search for innovative therapies. Necroptosis is recognized as a key anti-tumor mechanism, and microRNA-mediated necroptosis has been linked to tumor progression. This study investigates how miR‑10b‑5p regulates necroptosis in LUAD. miRNA sequencing and database integration identify candidate targets, while immunohistochemistry confirms miR‑10b‑5p upregulation in LUAD tissues. Functional assays in LUAD cell lines and xenograft models evaluate effects on cellular activity and in vivo growth. Results show miR‑10b‑5p suppresses necroptosis by downregulating PKP3 and inhibiting RIPK3/MLKL signaling, whereas PKP3 knockdown reverses the effects.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/induction-of-necroptosis-in-lung-adenocarcinoma-by-mir10b5p-through-modulation-of-the-pkp3ripk3mlkl-cascade/364952/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/induction-of-necroptosis-in-lung-adenocarcinoma-by-mir10b5p-through-modulation-of-the-pkp3ripk3mlkl-cascade/364952.png","ImageObject",300,407,{"name":42,"@type":43},"River Wang","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-23","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",6,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is the main objective of the study in LUAD?","Question",{"text":63,"@type":64},"To determine how miR‑10b‑5p regulates necroptosis in lung adenocarcinoma and to clarify the underlying mechanism involving the PKP3/RIPK3/MLKL cascade.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How was the relationship between miR‑10b‑5p and PKP3 tested?",{"text":68,"@type":64},"The study used a dual luciferase reporter system to show that PKP3 is a direct target negatively regulated by miR‑10b‑5p, and assessed pathway changes by western blotting.",{"name":70,"@type":61,"acceptedAnswer":71},"What happens to LUAD growth and necroptosis when miR‑10b‑5p levels are altered?",{"text":72,"@type":64},"Elevated miR‑10b‑5p enhances LUAD cell proliferation and suppresses necroptosis by inhibiting RIPK3/MLKL signaling. Inhibition of miR‑10b‑5p activates the RIPK3/MLKL pathway, promotes necroptosis, and significantly reduces LUAD growth in vivo.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},364952,1790188468,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,105,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},"Technology",50,"technology",{"id":106,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},7,"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},1099514067438,"https://ap-avatar.wpscdn.com/avatar/100002539ee87300030?x-image-process=image/resize,m_fixed,w_180,h_180&k=1780474512215547542","ONCOLOGY REPORTS 53: 56, 2025  \nInduction of necroptosis in lung adenocarcinoma by miR‑10b‑5p through modulation of the PKP3/RIPK3/MLKL cascade  \nYING HU 1* , XIN LIU2* , ZIHENG YUAN 1* , JIANPING HE3 , RUN MA 1 , YUMING WANG 1 and GENFAYI4  \n1Department of Laboratory, The Second Affiliated Hospital of Kunming Medical University, Kunming, Yunnan 650101, P.R. China; 2Department of Thoracic Surgery, The Second Affiliated Hospital of Kunming Medical University,  \n3  \nKunming, Yunnan 650101, P.R. China; Department of Medical Genetics and Prenatal Diagnosis, Kunming Maternal and Child Health Centre, Kunming, Yunnan 650032, P.R. China; 4Department of Medical Imaging, The First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan 650051, P.R. China  \nReceived October 16, 2024; Accepted February 20, 2025  \nDOI: 10. 3892/or.2025.8889  \nAbstract. Globally, lung adenocarcinoma (LUAD) remains the leading cause of cancer‑related mortality, highlighting the urgent need for innovative therapeutic approaches. Necroptosis has been recognized as a crucial mechanism for inhibiting cancer progression. Research has revealed a significant asso‑ ciation between microRNA (miRNA)‑mediated necroptosisand tumor progression. The present study aimed to elucidate the role and underlying mechanisms of miR‑10b‑5p in regu‑ lating necroptosis in the context of LUAD. In an investigation of LUAD, miRNA sequencing was conducted on both LUAD and adjacent non‑tumor tissues, followed by the integration of external database information to identify specific target miRNAs. The expression of miR‑10b‑5p was verified in LUAD tissues and corresponding adjacent non‑cancerous tissues using immunohistochemistry. In vitro experiments, utilizing LUAD cell lines engineered to modulate miR‑10b‑5p levels, assessed its effects on cellular activities and necroptosis. The inhibition of PKP3 by miR‑10b‑5p was determined using a dual lucif‑ erase reporter system. Furthermore, alterations in miR‑10b‑5p levels were found to affect PKP3 expression and inhibit the RIPK3/MLKL signaling pathway, as evidenced by western blot analysis in LUAD cell lines. The effect of PKP3 knockdown  \nCorrespondence to: Professor Yuming Wang, Department of Laboratory, The Second Affiliated Hospital of Kunming Medical University, 374 Dianmeng Avenue, Wuhua, Kunming, Yunnan 650101, P.R. China  \nE‑[mail: wangym992011@163.com](mail: wangym992011@163.com)  \nProfessor Genfa Yi, Department of Medical Imaging, The First Affiliated Hospital of Kunming Medical University, 374 Dianmeng Avenue, Wuhua, Kunming, Yunnan 650051, P.R. China  \nE‑mail: [genfa@kmmu.edu.cn](genfa@kmmu.edu.cn)  \n*Contributed equally  \nKey words: lung adenocarcinoma, microRNA‑10b‑5p, necroptosis, PKP3, RIPK3/MLKL  \non cell activity and necroptosis in LUAD cell lines with low miR‑10b‑5p expression levels was assessed using cell function assays. Finally, a nude mouse xenograft model was used to investigate the effect of miR‑10b‑5p on LUAD growth in vivo and its specific mechanism of action. It has been revealed that miR‑10b‑5p levels are significantly elevated in LUAD speci‑ mens. Further investigations demonstrated that an increase in miR‑10b‑5p enhances the proliferation of LUAD cells and suppresses the progression of necroptosis, as evidenced by in vitro experiments. Through dual luciferase reporter assays, PKP3 was confirmed as a direct target negatively regulated by miR‑10b‑5p, leading to reduced expression levels. Western blot analysis indicated that miR‑10b‑5p inhibits the RIPK3/MLKL pathway activation through downregulation of PKP3, which leads to increased cell proliferation and decreased necroptosis. However, knockdown of PKP3 reversed the inhibitory effect of miR‑10b‑5p inhibitors on cellular activity and inhibited necrosis by suppressing the RIPK3/MLKL signalling pathway. In addition, animal model studies demonstrated that inhibi‑ tion of miR‑10b‑5p activated the RIPK3/MLKL pathway by promoting PKP3 expression and significant","cbCaidiuDTDQWwCd","https://ap.wps.com/l/cbCaidiuDTDQWwCd","pdf",8184584,14,"English","# Introduction\n## Necroptosis and microRNA context in LUAD\n# Materials and Methods\n## miRNA sequencing and target identification\n## Verification by immunohistochemistry\n## Cell-based assays and pathway analysis\n## Nude mouse xenograft model\n# Results\n## miR‑10b‑5p expression changes in LUAD\n## Direct targeting of PKP3 by miR‑10b‑5p\n## Regulation of RIPK3/MLKL signaling and necroptosis\n# Conclusion\n## miR‑10b‑5p as a therapeutic target via necroptosis modulation","[{\"question\":\"What is the main objective of the study in LUAD?\",\"answer\":\"To determine how miR‑10b‑5p regulates necroptosis in lung adenocarcinoma and to clarify the underlying mechanism involving the PKP3/RIPK3/MLKL cascade.\"},{\"question\":\"How was the relationship between miR‑10b‑5p and PKP3 tested?\",\"answer\":\"The study used a dual luciferase reporter system to show that PKP3 is a direct target negatively regulated by miR‑10b‑5p, and assessed pathway changes by western blotting.\"},{\"question\":\"What happens to LUAD growth and necroptosis when miR‑10b‑5p levels are altered?\",\"answer\":\"Elevated miR‑10b‑5p enhances LUAD cell proliferation and suppresses necroptosis by inhibiting RIPK3/MLKL signaling. Inhibition of miR‑10b‑5p activates the RIPK3/MLKL pathway, promotes necroptosis, and significantly reduces LUAD growth in vivo.\"}]","Induction of necroptosis in lung adenocarcinoma by miR‑10b‑5p through modulation of the PKP3/RIPK3/MLKL cascade | PDF",1790159508,35,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/88446e1f33392fbbbfce9ccd3f27b9e5.webp",983,1357,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/80c76a812685775d5c5256c595bf554d.webp",982,1356,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/125dce58e80a3a2efb1d9c0ee063e8c6.webp",981,1354,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/227e4b06bb08e2d6cf4c228f687a9241.webp",980,1353]